Interleukin-2-inducible T-cell kinase inhibitors modify functional polarization of human peripheral T-cell lymphoma cells.

Mamand, Sami; Carr, Matthew; Allchin, Rebecca L; Ahearne, Matthew J; Wagner, Simon D

Mamand, Sami; Carr, Matthew; Allchin, Rebecca L; Ahearne, Matthew J; Wagner, Simon D.

Afiliação

Mamand S; Leicester Cancer Research Centre and Ernest and Helen Scott Haematology Research Institute, University of Leicester, Leicester, United Kingdom.
Carr M; Leicester Cancer Research Centre and Ernest and Helen Scott Haematology Research Institute, University of Leicester, Leicester, United Kingdom.
Allchin RL; Leicester Cancer Research Centre and Ernest and Helen Scott Haematology Research Institute, University of Leicester, Leicester, United Kingdom.
Ahearne MJ; Leicester Cancer Research Centre and Ernest and Helen Scott Haematology Research Institute, University of Leicester, Leicester, United Kingdom.
Wagner SD; Leicester Cancer Research Centre and Ernest and Helen Scott Haematology Research Institute, University of Leicester, Leicester, United Kingdom.

Blood Adv ; 3(5): 705-710, 2019 03 12.

Article em En | MEDLINE | ID: mdl-30814054

Assuntos

Polaridade Celular/efeitos dos fármacos; Linfoma de Células T Periférico/patologia; Inibidores de Proteínas Quinases/farmacologia; Proteínas Tirosina Quinases/antagonistas & inibidores; Adulto; Idoso; Linfócitos T CD4-Positivos/fisiologia; Diferenciação Celular/efeitos dos fármacos; Linhagem Celular; Feminino; Humanos; Linfócitos T Reguladores

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Tirosina Quinases / Linfoma de Células T Periférico / Polaridade Celular / Inibidores de Proteínas Quinases Limite: Adult / Aged / Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google